Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: Systematic review and meta-analysis

British Journal of General Practice

Volumn 60, Issue 579, 2010, Pages

  McNally, Maggie ^a   Curtain, James ^b   O'Brien, Kirsty K ^a   Dimitrov, Borislav D ^a   Fahey, Tom ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

General practice; Meta analysis; Pneumonia; Prognosis; Severity of illness index

Indexed keywords

ARTICLE; BREATHING RATE; BRITISH NURSING INDEX; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EMBASE; GENERAL PRACTICE; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDLINE; MORTALITY; PNEUMONIA; PREDICTION; PROBABILITY; PSYCINFO; QUALITY CONTROL; SCORING SYSTEM; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; VALIDATION STUDY; VALIDITY;

EID: 78650562010     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X532422     Document Type: Article

References (37)

1. Committee BSoC. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56(suppl 4): IV1-64.
2. Hak E, Bont J, Hoes AW, Verheij TJ. Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care. Fam Pract 2005; 22(4): 375-380.
3. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58(5): 377-382.
4. Macfkrlane JT, Boldy D. 2004 update of BTS pneumonia guidelines: what's new? Thorax 2004; 59(5): 364-366.
5. McGinn TG, Guyatt GH, Wyer PC, et al. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA 2000; 284(1): 79-84.
6. Moons KG, Royston P, Vergouwe Y, et al. Prognosis and prognostic research: what, why, and how? BMJ 2009; 338: b375.
7. Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006; 144(3): 201-209.
8. Bont J, Hak E, Hoes AW, et al. Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB-65 severity assessment tool, Arch Intern Med 2008; 168(13): 1465-1468.
9. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model, BMJ 2009; 338: b605.
10. Ingui BJ, Rogers MA. Searching for clinical prediction rules in MEDLINE. J Am Med Inform Assoc 2001; 8(4): 391-397.
11. Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 2007; 62(3): 253-259.
12. Bauer TT, Ewig S, Marre R, et al. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006; 260(1): 93-101.
13. Buising KL, Thursky KA, Black JF, et al. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas 2007; 19(5): 418-426.
14. Capelastegui A, Espana PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006; 27(1): 151-157.
15. Chalmers JD, Singanayagam. A, Hill AT. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 2008; 63(8): 698-702.
16. Kruger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008; 31 (2): 349-355.
17. Man SY, Lee N, Ip M, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007; 62(4): 348-353.
18. Menendez R, Martinez R, Reyes S, et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009; 64(7): 556-558.
19. Schaaf B, Kruse J, Rupp J, et al. Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia. Eur Respir J 2007; 30(3): 517-524.
20. Schuete P, Koller M, Christ-Grain M, et al. Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings. Epidemiol Infect 2008; 136(12): 1628-1637.
21. Zuberi FF, Khan JA. Prospective comparison of prediction rules of mortality risk for CAP in a developing country. Int J Tuberc Lung Dis 2008; 12(4): 447-152.
22. Ewig S, Birkner N, Strauss R, et al. New perspectives on communityacquired pneumonia in 388, 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality, Thorax 2009; 64(12): 1016-1017.
23. Myint PK, Kamath AV, Vowler SL, et al. Severity assessment criteria recommended by the British Thoracic Society (BTS) for communityacquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts, Age Ageing 2006; 35(3): 286-291.
24. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(suppl 2): S27-72.
25. Singanayagam A, Chalmers JD, Hill AT. Severity assessment in community-acquired pneumonia: a review. QJM 2009; 102(6): 379-388.
26. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rales for prognosis in communityacquired pneumonia. Am J Med 2005; 118(4): 384-392.
27. Buising KL, Thursky KA, Black JF, et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006; 61(5): 419-424.
28. Espana PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe communityacquired pneumonia. Am J Respir Cut Care Med 2006; 174(11): 1249-1256.
29. Ewig S, de Roux A, Bauer T, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004; 59(5): 421-427.
30. Bont J, Hak E, Hoes AW, et al. A prediction rule for elderly primarycare patients with lower respiratory tract infections. Eur Respir J 2007; 29(5): 969-975.
31. Venmans LM, Bont J, Gorter KJ, et al. Prediction of complicated lower respiratory tract infections in older patients with diabetes. Br J Gen Pract 2008; 58(553): 564-568.
32. Van de Nadort C, Smeets HM, Bont J, et al. Prognosis of primary care patients aged 80 years and older with lower respiratory tract infection. Br J Gen Pract 2009; 59(561): e110-115.
33. Seppa Y, Bloigu A, Honkanen PO, et al. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med 2001; 161(22): 2709-2713.
34. Kothe H, Bauer T, Marre R, et al. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 2008; 32(1): 139-146.
35. Falk G, Fahey T. C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies. Eam Pract 2009; 26(1): 10-21.
36. Huang DT, Weissteld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008; 52(1): 48-58 e2.
37. Chalkidou K, Walley T, Culyer A, et al. Evidence-informed evidencemaking. J Health Serv Res Policy 2008; 13(3): 167-173.